Omeprazole + DomperidoneThird Party Manufacturing in India

Omeprazole + Domperidone works by combining acid reduction with improved gastric motility to treat complex acid-related disorders.

Omeprazole acts as a proton pump inhibitor, blocking the H+/K+ ATPase enzyme in the stomach lining to profoundly reduce acid secretion. Simultaneously, Domperidone acts as a peripheral dopamine (D2) receptor antagonist. It increases esophageal sphincter pressure and enhances gastric emptying without affecting gastric acid production. This dual action helps the body heal mucosal damage while preventing the upward flow of stomach contents.

Unlike single-agent therapies, Omeprazole + Domperidone provides comprehensive relief from both acidity and accompanying symptoms like nausea and bloating. It is highly effective for patients requiring rapid and comprehensive symptom management.

Therapeutic Uses

Omeprazole + Domperidone is prescribed for the treatment of:

• Gastroesophageal Reflux Disease (GERD): Specially effective when GERD is accompanied by symptoms like nausea, vomiting, or delayed gastric emptying.
• Dyspepsia: Treats indigestion and persistent fullness after meals.
• Peptic Ulcers with Nausea: Manages ulcers while controlling associated emetic symptoms.

Why Manufacturers Choose Omeprazole + Domperidone

Fixed-dose combinations (FDCs) like Omeprazole + Domperidone are extremely popular in the Indian domestic market due to their convenience and dual-action efficacy. The combination addresses multiple gastrointestinal complaints in a single dose, driving high prescription volumes from general physicians and gastroenterologists.

This makes Omeprazole + Domperidone one of the most sought-after combinations for third party manufacturing in India, offering excellent commercial value for PCD franchise operators.